BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells

Oncogene

Volumn 22, Issue 29, 2003, Pages 4459-4468

  Kurosu, Tetsuya ^a   Fukuda, Tetsuya ^a   Miki, Tohru ^a   Miura, Osamu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; BCL6; Chemotherapeutic reagents; Etoposide; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; B LYMPHOCYTE RECEPTOR; ETOPOSIDE; PROTEASOME; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BCL6 GENE; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NONHODGKIN LYMPHOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN DEGRADATION; SOMATIC MUTATION;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA-BINDING PROTEINS; DOXYCYCLINE; ETOPOSIDE; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUPEPTINS; LYMPHOMA, B-CELL; MEMBRANE POTENTIALS; MITOCHONDRIA; MULTIENZYME COMPLEXES; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0043170892     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206755     Document Type: Article

References (39)

1. Albagli O, Lantoine D, Quief S, Quignon F, Englert C, Kerckaert JP, Montarras D, Pinset C and Lindon C. (1999). Oncogene, 18, 5063-5075.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byd JC, Botstein D, Brown PO and Staudt LM. (2000). Nature, 403, 503-511.
3. Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR and Staudt LM. (1996). Blood, 87, 5257-5268.
4. Barrans SL, O'Connor SJ, Evans PA, Davies FE, Owen RG, Haynes AP, Morgan GJ and Jack AS. (2002). Br. J. Haematol., 117, 322-332.
5. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F, Fruchart C, Duval C, Monconduit M and Tilly H. (1994). Blood, 83, 2423-2427.
6. Bereshchenko OR, Gu W and Dalla-Favera R. (2002). Nat. Genet., 32, 606-613.
7. Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louie DC, Offit K, Chaganti RS and Dalla-Favera R. (1995). Blood, 86, 45-53.
8. Chabner BA and Longo DL (eds) (2001). Cancer Chemotherapy and Biotherapy: Principles and Practice. Lippincott Williams and Wilkins: Philadelphia.
9. Chen W, Iida S, Louie DC, Dalla-Favera R and Chaganti RS. (1998). Blood, 91, 603-607.
10. Dent AL, Shaffer AL, Yu X, Allman D and Staudt LM. (1997). Science, 276, 589-592.
11. Dent AL, Vasanwala FH and Toney LM. (2002). Crit. Rev. Oncol. Hematol., 41, 1-9.
12. Dvorakova K, Waltmire CN, Payne CM, Tome ME, Briehl MM and Dorr RT. (2001). Blood, 97, 3544-3551.
13. Fleury C, Mignotte B and Vayssiere JL. (2002). Biochimie, 84, 131-141.
14. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N and Tokuhisa T. (1997). J. Exp. Med., 186, 439-448.
15. Jabs T. (1999). Biochem Pharmacol, 57, 231-245.
16. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G and Bastard C. (1993). Nat. Genet., 5, 66-70.
17. Kikuchi M, Miki T, Kumagai T, Fukuda T, Kamiyama R, Miyasaka N and Hirosawa S. (2000). Oncogene, 19, 4941-4945.
18. Kojima S, Hatano M, Okada S, Fukuda T, Toyama Y, Yuasa S, Ito H and Tokuhisa I. (2001). Development, 128, 57-65.
19. Kumagai T, Miki T, Kikuchi M, Fukuda T, Miyasaka N, Kamiyama R and Hirosawa S. (1999). Oncogene, 18, 467-475.
20. Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RS and Dalla-Favera R. (1994). Blood, 83, 1757-1759.
21. Lossos IS, Jones CD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, Tibshirani R and Levy R. (2001). Blood, 98, 945-951.
22. Miki T, Kawamata N, Hirosawa S and Aoki N. (1994). Blood, 83, 26-32.
23. Nakamura Y. (2000). Leuk. Lymphoma, 38, 505-512.
24. Niu H. (2002). Hematol. Oncol., 20, 155-166.
25. Niu H, Ye BH and Dalla-Favera R. (1998). Genes Dev., 12, 1953-1961.
26. Ohno H and Fukuhara S. (1997). Leuk. Lymphoma, 27, 53-63.
27. Onizuka T, Moriyama M, Yamochi T, Kuroda T, Kazama A, Kanazawa N, Sato K, Kato T, Ota H and Mori S. (1995). Blood, 86, 28-37.
28. Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES and Raffeld M. (1995). Blood, 85, 2877-2884.
29. Rothe G and Valet G. (1990). J. Leukoc. Biol., 47, 440-448.
30. Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, Pickeral OK and Staudt LM. (2001). Immunity, 15, 375-385.
31. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP and Staudt LM. (2000). Immunity, 13, 199-212.
32. Tang TT, Dowbenko D, Jackson A, Toney L, Lewin DA, Dent AL and Lasky LA. (2002). J. Biol. Chem., 277, 14255-14265.
33. Wang X, Li Z, Naganuma A and Ye BH. (2002). Proc. Natl. Acad. Sci. USA, 99, 15018-15023.
34. Yamochi T, Kaneita Y, Akiyama T, Mori S and Moriyama M. (1999). Oncogene, 18, 487-494.
35. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP and Dalla-Favera R. (1997). Nat. Genet., 16, 161-170.
36. Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS and Dalla-Favera R. (1995). EMBO J., 14, 6209-6217.
37. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS and Dalla-Favera R. (1993). Science, 262, 747-750.
38. Yee JK, Miyanohara A, LaPorte P, Bouic K, Burns JC and Friedmann T. (1994). Proc. Natl. Acad. Sci. USA, 91, 9564-9568.
39. Zamzami N and Kroemer G. (2001). Nat. Rev. Mol. Cell Biol., 2, 67-71.